Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature

American Journal of Surgery

Volumn 195, Issue 4, 2008, Pages 508-520

  Garrean, Sean ^a   Hering, Justin ^a   Saied, Abdul ^a   Helton, W Scott ^b   Espat, N Joseph ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Colorectal hepatic metastases; Hepatic tumors; Hepatocellular cancer; Radiofrequency ablation; RFA

Indexed keywords

CANCER SURVIVAL; HUMAN; LAPAROSCOPY; LIVER CANCER; LIVER METASTASIS; LONG TERM CARE; PRIORITY JOURNAL; RADIATION SAFETY; RADIOFREQUENCY ABLATION; RECURRENCE RISK; REVIEW; SKIN ABSORPTION; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COLORECTAL NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; ITALY; JAPAN; LIVER NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 40949089014     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.06.024     Document Type: Review

References (42)

1. Curley S.A. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10 (2003) 338-347
2. Buscarini L., Buscarini E., Di Stasi M., et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11 (2001) 914-921
3. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
4. Raut C.P., Izzo F., Marra P., et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12 (2005) 616-628
5. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103 (2005) 1201-1209
6. Guglielmi A., Ruzzenente A., Battocchia A., et al. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 50 (2003) 480-484
7. Giovannini M., Moutardier V., Danisi C., et al. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients. J Gastrointest Surg 7 (2003) 791-796
8. Shibata T., Shibata T., Maetani Y., et al. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 238 (2006) 346-353
9. Berber E., Rogers S., and Siperstein A. Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study. Surg Endosc 19 (2005) 710-714
10. Poon R.T., Ng K.K., Lam C.M., et al. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 11 (2004) 281-289
11. Lin S.M., Lin C.J., Lin C.C., et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54 (2005) 1151-1156
12. Lin S.M., Lin C.J., Lin C.C., et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127 (2004) 1714-1723
13. Shiina S., Teratani T., Obi S., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 (2005) 122-130
14. Omata M., Tateishi R., Yoshida H., et al. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 127 (2004) S159-S166
15. Chen M.S., Zhang Y.J., Li J.Q., et al. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 27 (2005) 623-625
16. Lu M.D., Xu H.X., Xie X.Y., et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 40 (2005) 1054-1060
17. Chen M.S., Li J.Q., Liang H.H., et al. [Comparison of effects of percutaneous radiofrequency ablation and surgical resection on small hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi 85 (2005) 80-83
18. Cho C.M., Tak W.Y., Kweon Y.O., et al. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma]. Korean J Hepatol 11 (2005) 59-71
19. Hong S.N., Lee S.Y., Choi M.S., et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39 (2005) 247-252
20. Montorsi M., Santambrogio R., Bianchi P., et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 9 (2005) 62-67
21. Vivarelli M., Guglielmi A., Ruzzenente A., et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240 (2004) 102-107
22. Curley S.A., Izzo F., Delrio P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230 (1999) 1-8
23. De Baere T., Elias D., Dromain C., et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175 (2000) 1619-1625
24. Guilliams A.R., and Lees W.R. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 43 (2000) 656-666
25. Guilliams A.R., and Lees W.R. Radiofrequency of colorectal liver metastasis. Abdom Imaging 30 (2005) 419-426
26. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 (2001) 159-166
27. Curley S.A. Outcomes after surgical treatment of colorectal cancer liver metastases. Semin Oncol 32 (2005) S109-S111
28. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825
29. Dematteo R.P., Palese C., Jarnagin W.R., et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4 (2000) 178-184
30. Elias D., Baton O., Sideris L., et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 90 (2005) 36-42
31. Cheng J., Glasgow E., O'Rourke, et al. Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases. Surg Endosc 17 (2003) 61-67
32. Scaife C.L., Curley S.A., Izzo F., et al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol 10 (2003) 348-354
33. Machi J., Oishi A.J., Sumida K., et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12 (2006) 318-326
34. Scaife C.L., and Curley S.A. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 12 (2003) 243-255
35. Kosari K., Gomes M., Hunter D., et al. Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg 6 (2002) 255-263
36. Amersi F.F., McElrath-Garza A., Ahmad A., et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141 (2006) 581-587
37. Ahmad A., Chen S.L., Kavanagh M.A., et al. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?. Am Surg 72 (2006) 875-879
38. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
39. Kerr D.J., McArdle C.S., Ledermann J., et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361 (2003) 368-373
40. Pawlik T.M., Izzo F., Cohen D.S., et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10 (2003) 1059-1069
41. Curley S.A., Bilchik A.J., Fraker D., et al. Radiofrequency ablation of hepatic malignancies. Contemp Surg 59 (2006) 162-172
42. Tanabe K.K., Curley S.A., Dodd G.D., et al. Radiofrequency ablation: the experts weigh in. Cancer 100 (2004) 641-650